BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8020659)

  • 21. 1-ethyl and 1-propylazacycloalkan-2-one ester prodrugs of ketoprofen. Synthesis, chemical stability, enzymatic hydrolysis, anti-inflammatory activity, and gastrointestinal toxicity.
    Bonina FP; Puglia C; Ventura D; Santagati NA; Saija A; Trombetta D
    Arzneimittelforschung; 2002; 52(12):884-9. PubMed ID: 12572528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2.
    Wallace JL; McKnight W; Reuter BK; Vergnolle N
    Gastroenterology; 2000 Sep; 119(3):706-14. PubMed ID: 10982765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide-releasing NSAIDs: a review of their current status.
    Fiorucci S; Antonelli E; Burgaud JL; Morelli A
    Drug Saf; 2001; 24(11):801-11. PubMed ID: 11665868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.
    Jarosz M; Szkaradek N; Marona H; Nowak G; Młyniec K; Librowski T
    Inflammopharmacology; 2017 Dec; 25(6):653-663. PubMed ID: 28536986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury.
    Huang J; Moochhala SM; Moore PK; Bhatia M
    Shock; 2005 Aug; 24(2):182-7. PubMed ID: 16044091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects.
    Davies NM; Røseth AG; Appleyard CB; McKnight W; Del Soldato P; Calignano A; Cirino G; Wallace JL
    Aliment Pharmacol Ther; 1997 Feb; 11(1):69-79. PubMed ID: 9042976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric toxicity of racemic ketoprofen and its enantiomers in rat: oxygen radical generation and COX-expression.
    Alarcón de la Lastra C; Nieto A; Martín MJ; Cabré F; Herrerías JM; Motilva V
    Inflamm Res; 2002 Feb; 51(2):51-7. PubMed ID: 11930903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flurbiprofen-antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling.
    Ashraf Z; Alamgeer ; Kanwal M; Hassan M; Abdullah S; Waheed M; Ahsan H; Kim SJ
    Drug Des Devel Ther; 2016; 10():2401-19. PubMed ID: 27555750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic Effect of the Newly Developed S(+)-Flurbiprofen Plaster on Inflammatory Pain in a Rat Adjuvant-Induced Arthritis Model.
    Sugimoto M; Toda Y; Hori M; Mitani A; Ichihara T; Sekine S; Hirose T; Endo H; Futaki N; Kaku S; Otsuka N; Matsumoto H
    Drug Dev Res; 2016 Feb; 77(1):20-8. PubMed ID: 26763139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of glucosamine sulfate on the analgesic and ulcerogenic activity of ketoprofen].
    Violin BV; Kompantsev DV; Pogorelyĭ VE; Makarova LM; Kompantseva EV; Leonova VN
    Eksp Klin Farmakol; 2007; 70(3):53-5. PubMed ID: 17650636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
    Muscará MN; McKnight W; Asfaha S; Wallace JL
    Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate.
    Jansson EA; Petersson J; Reinders C; Sobko T; Björne H; Phillipson M; Weitzberg E; Holm L; Lundberg JO
    Free Radic Biol Med; 2007 Feb; 42(4):510-8. PubMed ID: 17275683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ML 3000 reduces gastric prostaglandin synthesis without causing mucosal injury.
    Wallace JL; Carter L; McKnight W; Tries S; Laufer S
    Eur J Pharmacol; 1994 Dec; 271(2-3):525-31. PubMed ID: 7705453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focused antithrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first-pass detoxification than aspirin in rats.
    Hung DY; Mellick GD; Masci PP; Whitaker AN; Whitehouse MW; Roberts MS
    J Lab Clin Med; 1998 Dec; 132(6):469-77. PubMed ID: 9851736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antinociceptive activity of two new NO-releasing derivatives of the NSAID S-ketoprofen in rats.
    Gaitan G; Ahuir FJ; Del Soldato P; Herrero JF
    Br J Pharmacol; 2004 Nov; 143(5):533-40. PubMed ID: 15451773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent effects of ketoprofen on the human gastric mucosa in comparison with ibuprofen.
    Donnelly MT; Richardson P; Hawkey CJ; Courtauld E; Stack WA
    Aliment Pharmacol Ther; 2000 May; 14(5):543-9. PubMed ID: 10792116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gastroprotective role of glucocorticoid hormones during action of nonsteroidal anti-inflammatory drugs].
    Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2009 Mar; 95(3):250-61. PubMed ID: 19449781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.